Graham Collins/X
Jun 20, 2025, 16:16
Graham Collins: ctDNA in S1826 – Clearance at C3D1 Associated With PFS
Graham Collins, Associate Professor, Haematology and Lymphoma Specialist at Oxford Cancer and Haematology Centre, shared a post on X:
“Herrera et al – ctDNA in S1826
• 97% ctDNA + baseline
• clearance at C3D1 associated with PFS
• within pos patients, those with minor associated with esp poor outcomes
• EOT ctDNA detection also associated with poor outcomes CtDNA ripe for response adapted trials.”
More posts featuring Graham Collins on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 10, 2025, 06:53
Jul 9, 2025, 23:47
Jul 9, 2025, 23:31
Jul 9, 2025, 23:14
Jul 9, 2025, 23:06
Jul 9, 2025, 22:41